Zimbus Breezhaler is an asthma medicine for inhalation. It is used for maintenance (regular) treatment in adults whose asthma is not controlled well enough with inhaled long\-acting beta\-2 agonist together with a high dose of an inhaled corticosteroid. It should be used for patients who have had at least one asthma attack (exacerbations) in the last year. Zimbus Breezhaler contains the active substances indacaterol, glycopyrronium bromide and mometasone.
Therapeutic Indication
Maintenance treatment of asthma in adults whose disease is not adequately controlled.
Therapeutic Area (MeSH)
ATC Code
R03AL
ATC Item
N/A
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
EMA Name
Zimbus Breezhaler
Medicine Name
Zimbus Breezhaler
Aliases
N/ANo risk management plan link.
